Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

The UK-PSCSC Consortium, Liu, Jimmy Z, The International IBD Genetics Consortium, The International PSC Study Group, Hov, Johannes Roksund, Folseraas, Trine, Ellinghaus, Eva, Rushbrook, Simon M +79 more·2013·Nature Genetics

Cited by (392)

Items 201–300 of 392

  1. Genetic architecture of human fibrotic diseases: disease risk and disease progression
    Agnès Gardet, Timothy S. Zheng, Joanne L. Viney · 2013 · Frontiers in Pharmacology
  2. Review article: next‐generation transformative advances in the pathogenesis and management of autoimmune hepatitis
    Albert J. Czaja · 2017 · Alimentary Pharmacology & Therapeutics
  3. Characterization of the gut microbiota in patients with primary sclerosing cholangitis compared to inflammatory bowel disease and healthy controls
    Samaneh Ostadmohammadi, Masoumeh Azimirad, Hamidreza Houri, Kaveh Naseri, Ehsan Javanmard, Hamed Mirjalali, Abbas Yadegar, Amir Sadeghi, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali · 2021 · Molecular Biology Reports
  4. Biomarkers for disease progression of primary sclerosing cholangitis
    Elisabeth M. G. de Vries, Ulrich H. Beuers, Cyriel Y. Ponsioen · 2015 · Current Opinion in Gastroenterology
  5. Immunochip Identifies Novel, and Replicates Known, Genetic Risk Loci for Rheumatoid Arthritis in Black South Africans
    Nimmisha Govind, Ananyo Choudhury, Bridget Hodkinson, Claudia Ickinger, Jacqueline Frost, Annette Lee, Peter K. Gregersen, Richard J. Reynolds, S. Louis Bridges, Scott Hazelhurst et al. · 2014 · Molecular Medicine
  6. Bile Acids-Based Therapies for Primary Sclerosing Cholangitis: Current Landscape and Future Developments
    Stefano Fiorucci, Ginevra Urbani, Cristina Di Giorgio, Michele Biagioli, Eleonora Distrutti · 2024 · Cells
  7. A Gradient of Intestinal Inflammation in Primary Sclerosing Cholangitis
    Agnes Wittek, Babett Steglich, Christian Casar, Oliver Seiz, Philipp Huber, Hanno Ehlken, Dominik Reher, Sandra Wende, Tanja Bedke, Jan Kempski et al. · 2023 · Inflammatory Bowel Diseases
  8. Ulcerative Colitis with and without Primary Sclerosing Cholangitis: Two Different Diseases?
    Atsushi Tanaka, Joachim C. Mertens · 2016 · Inflammatory Intestinal Diseases
  9. Crosstalk between the gut and the liver via susceptibility loci: Novel advances in inflammatory bowel disease and autoimmune liver disease
    Xinyang Li, Jun Shen, Zhihua Ran · 2016 · Clinical Immunology
  10. Immunogenetics in primary sclerosing cholangitis
    Brian K. Chung, Gideon Morris Hirschfield · 2017 · Current Opinion in Gastroenterology
  11. Genetic aspects of adult and pediatric autoimmune hepatitis: A concise review
    Bastian Engel, Alena Laschtowitz, Maciej K. Janik, Norman Junge, Ulrich Baumann, Piotr Milkiewicz, Richard Taubert, Marcial Sebode · 2021 · European Journal of Medical Genetics
  12. Immunobiology of primary sclerosing cholangitis
    Cornillet, Martin, Geanon, Daniel, Bergquist, Annika, Björkström, Niklas K. · 2025 · Hepatology
  13. Beyond heritability: improving discoverability in imaging genetics
    Chun Chieh Fan, Olav Bjerkehagen Smeland, Andrew Joseph Schork, Chi‐Hua Chen, Dominic Holland, Min‐Tzu Lo, V. S. Sundar, Oleksandr Frei, Terry L. Jernigan, Ole A. Andreassen et al. · 2018 · Human Molecular Genetics
  14. Accurate error control in high‐dimensional association testing using conditional false discovery rates
    James Liley, Chris Wallace · 2021 · Biometrical Journal
  15. Pharmacological interventions for primary sclerosing cholangitis
    Francesca Saffioti, Kurinchi Selvan Gurusamy, Neil Hawkins, Clare D Toon, Emmanuel A. Tsochatzis, Brian Ritchie Davidson, Douglas Thorburn · 2017 · Cochrane Database of Systematic Reviews
  16. C77G in PTPRC (CD45) is no risk allele for ovarian cancer, but associated with less aggressive disease
    Johannes Landskron, Sigrid Marie Kraggerud, Elisabeth Wik, Anne Dørum, Merete Bjørnslett, Espen Melum, Øystein Helland, Line Bjørge, Ragnhild A. Lothe, Helga Birgitte Salvesen et al. · 2017 · PLoS ONE
  17. PSC associated inflammatory bowel disease: a distinct entity
    Alireza Beheshti Maal, Atena Tamimi, Shahrokh Iravani, Arash Memarnejadian, Majid Sorouri, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali, Nikoo Hossein‐Khannazer, Massoud Vosough · 2022 · Expert Review of Gastroenterology & Hepatology
  18. Analysis of pleiotropic genetic effects on cognitive impairment, systemic inflammation, and plasma lipids in the Health and Retirement Study
    Michael William Lutz, Ramon Casanova, Santiago J. Saldana, Maragatha N. Kuchibhatla, Brenda L. Plassman, Kathleen M. Hayden · 2019 · Neurobiology of Aging
  19. Aging-Related Molecular Pathways in Chronic Cholestatic Conditions
    Claudio Pinto, Elisabetta Ninfole, A. Benedetti, Luca Maroni, Marco Marzioni · 2020 · Frontiers in Medicine
  20. Genetic risk variants for autoimmune diseases that influence gene expression in thymus
    Ingvild Gabrielsen, Silja Svanstrøm Amundsen, Hanna Helgeland, Siri T. Flåm, Nimo Hatinoor, Kristian Holm, Marte Kathrine Viken, Benedicte Alexandra Lie · 2016 · Human Molecular Genetics
  21. Statistical Learning Methods Applicable to Genome-Wide Association Studies on Unbalanced Case-Control Disease Data
    Xiaotian Dai, Guifang Fu, Shaofei Zhao, Yifei Zeng · 2021 · Genes
  22. HLA DQB1 alleles are related with nonalcoholic fatty liver disease
    Hamdi Levent Doğanay, Şeyma Katrinli, Yaşar Çolak, Ebubekir Şenateş, Ebru Itır Zemheri, Oğuzhan Öztürk, Feruze Yilmaz Enc, İlyas Tuncer, Gizem Dinler Doğanay · 2014 · Molecular Biology Reports
  23. Advances and controversies in the pathogenesis and management of primary sclerosing cholangitis
    Bertus Eksteen · 2014 · British Medical Bulletin
  24. Environmental Risk Factors of Pediatric‐Onset Primary Sclerosing Cholangitis and Autoimmune Hepatitis
    Andrea Tenca, Martti A. Färkkilä, Hannu Jalanko, Katariina Vapalahti, Johanna T. Arola, Tytti Jaakkola, Roberto Penagini, Olli P. Vapalahti, Kaija‐Leena Kolho · 2015 · Journal of Pediatric Gastroenterology and Nutrition
  25. The role of oral vancomycin in inducing remission for biologic-experienced ulcerative colitis with concomitant primary sclerosing cholangitis and liver transplantation
    Asad Ur Rahman, Faisal Inayat, Saeed Ali, Effa Zahid, Roger Charles · 2020 · Clinical Journal of Gastroenterology
  26. Current Therapeutics in Primary Sclerosing Cholangitis
    Natassia Tan, John Samuel Lubel, William W. Kemp, Stuart Keith Roberts, Ammar Majeed · 2023 · Journal of Clinical and Translational Hepatology
  27. Pathophysiological role of BACH transcription factors in digestive system diseases
    Qianben Song, Xin Mao, Mengjia Jing, Yu Fu, Wei Yan · 2023 · Frontiers in Physiology
  28. Antagonistic effects of the cytotoxic molecules granzyme B and TRAIL in the immunopathogenesis of sclerosing cholangitis
    Mareike Kellerer, Sana Javed, Christian Casar, Nico Will, Laura K. Berkhout, Dorothee Schwinge, Christian F. Krebs, Christoph Schramm, Katrin Neumann, Gisa Tiegs · 2024 · Hepatology
  29. MARC1 p.A165T variant is associated with decreased markers of liver injury and enhanced antioxidant capacity in autoimmune hepatitis
    Maciej K. Janik, Wiktor Smyk, Beata Kruk, Benedykt Szczepankiewicz, Barbara Górnicka, Magdalena Lebiedzińska, Yaiza Potes, Inês C. M. Simões, Susanne Nicole Weber, Frank Lammert et al. · 2021 · Scientific Reports
  30. Facing the challenges of multiscale modelling of bacterial and fungal pathogen–host interactions
    Jana Schleicher, Theresia Conrad, Mika Gustafsson, Gunnar Cedersund, Reinhard Guthke, Jörg Linde · 2016 · Briefings in Functional Genomics
  31. Efficacy and safety of immune-modulating therapy for primary sclerosing cholangitis: A systematic review and meta-analysis
    Xin Liu, Haolu Wang, Xinyao Liu, Kim R. Bridle, Dorothy H. Crawford, Xiaowen Liang · 2022 · Pharmacology & Therapeutics
  32. Autoimmune Pancreatitis in Patients with Inflammatory Bowel Disease: A Real-World Multicentre Collaborative ECCO CONFER Study
    Piotr Eder, Bram Verstockt, Emma Louise Culver, Gabriele Dragoni, Lea I. Kredel, Joanna Wypych, Ana García García de Paredes, Magdalena A. Kaniewska, Haim Leibovitzh, Triana Lobatón et al. · 2023 · Journal of Crohn s and Colitis
  33. Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives
    Rosanna Villani, Gaetano Serviddio, Carlo Avolio, Tommaso Cassano, Emanuele D’Amico · 2023 · Clinical and Experimental Medicine
  34. Imaging of autoimmune biliary disease
    Melinda J. Yeh, So Yeon Kim, Kartik S. Jhaveri, Spencer C. Behr, Nieun Seo, Benjamin M. Yeh · 2016 · Abdominal Radiology
  35. The genetic architecture of fornix white matter microstructure and their involvement in neuropsychiatric disorders
    Ya-Nan Ou, Yi-Jun Ge, Bang-Sheng Wu, Yi Zhang, Yu-Chao Jiang, Kevin Kuo, Liu Yang, L. Tan, Jian-Feng Feng, W. Cheng et al. · 2023 · Translational Psychiatry
  36. SAP interacts with CD28 to inhibit PD-1 signaling in T lymphocytes
    Sabina Sandigursky, Mark R. Philips, Adam Mor · 2020 · Clinical Immunology
  37. Genetic Risk Scores Identify Genetic Aetiology of Inflammatory Bowel Disease Phenotypes
    M D Voskuil, Lieke M. Spekhorst, Kimberley W. J. van der Sloot, Bernadien H. Jansen, Gerard D. H. Dijkstra, C. Janneke van der Woude, Frank Hoentjen, Marieke J. Pierik, Andrea E. van der Meulen‐de Jong, Nanne K.H. de Boer et al. · 2020 · Journal of Crohn s and Colitis
  38. B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis
    Maaike Biewenga, Sebastiaan Heidt, Manon Vergunst, Camiel J M Marijnissen, Rob A. de Man, Annemiek A. van der Eijk, Adriaan J. van der Meer, Leendert Adrianus Trouw, Bart van Hoek · 2022 · JHEP Reports
  39. Emerging treatments for primary sclerosing cholangitis
    Eduardo A. Rodríguez, Elizabeth J. Carey, Keith D. Lindor · 2017 · Expert Review of Gastroenterology & Hepatology
  40. HLA haplotypes in primary sclerosing cholangitis patients of admixed and non‐European ancestry
    Eva Kristine Klemsdal Henriksen, Marte Kathrine Viken, Michael Wittig, Kristian Holm, Trine Folseraas, Sören Mucha, Espen Melum, Johannes R. Hov, Lazaridis Kn, Brian D. Juran et al. · 2017 · HLA
  41. HLA variants related to primary sclerosing cholangitis influence rejection after liver transplantation
    Bjarte Fosby · 2014 · World Journal of Gastroenterology
  42. Immunochip analysis identifies novel susceptibility loci in the human leukocyte antigen region for acquired thrombotic thrombocytopenic purpura
    Ilaria Mancini, Isis Ricaño-Ponce, Emanuela Maria Pappalardo, Andrea Cairo, Marcin M. Gorski, Gloria Casoli, Barbara Ferrari, Marta Alberti, Danijela Miković, Marina Noris et al. · 2016 · Journal of Thrombosis and Haemostasis
  43. Cutting edge issues in juvenile sclerosing cholangitis
    Angelo Di Giorgio, Diego Vergani, Giorgina Mieli‐Vergani · 2021 · Digestive and Liver Disease
  44. Genetic Link between Rheumatoid Arthritis and Autoimmune Liver Diseases: A Two-Sample Mendelian Randomization Study
    Junyu Fan, Ting Jiang, Dongyi He · 2022 · Seminars in Arthritis and Rheumatism
  45. The Neglected Role of Bile Duct Epithelial Cells in NASH
    Massimiliano Cadamuro, Alberto Lasagni, Samantha Sarcognato, Maria Guido, Roberto Fabris, Mario Strazzabosco, Alastair J. Strain, Paolo Simioni, Erica Villa, Luca Fabris · 2021 · Seminars in Liver Disease
  46. Genetic factors affect the etiology, clinical characteristics and outcome of autoimmune hepatitis
    Takeji Umemura, Masao Ôta · 2015 · Clinical Journal of Gastroenterology
  47. Unbiased Characterization of Peptide-HLA Class II Interactions Based on Large-Scale Peptide Microarrays; Assessment of the Impact on HLA Class II Ligand and Epitope Prediction
    Mareike Wendorff, Heli M. Garcia Alvarez, Thomas Østerbye, Hesham ElAbd, Elisa Rosati, Frauke C. Degenhardt, Søren Buus, André Franke, Morten Nielsen · 2020 · Frontiers in Immunology
  48. Inflammatory pathways and cholangiocarcinoma risk mechanisms and prevention
    Massimiliano Cadamuro, Mario Strazzabosco · 2022 · Advances in cancer research
  49. Liver transplant in primary sclerosing cholangitis: Current trends and future directions
    Yash R. Shah, Natalia Nombera-Aznaran, David Guevara-Lazo, Ernesto Calderón Martinez, Angad Tiwari, Srilakshmidevi Kanumilli, Purva C. Shah, Bhanu Siva Mohan Pinnam, Hassam Ali, Dushyant Singh Dahiya · 2023 · World Journal of Hepatology
  50. Proteome-wide Mendelian randomization highlights AIF1 and HLA-DQA2 as targets for primary sclerosing cholangitis
    Lanlan Chen, Yuexuan Zhao, Mingyue Li, Guoyue Lv · 2023 · Hepatology International
  51. Biological basis of extensive pleiotropy between blood traits and cancer risk
    Miguel Ángel Pardo-Cea, Xavier Farré, Anna Esteve, Joanna Palade, Roderic Espín, Francesca Mateo, Eric B. Alsop, Marc Alorda, Natàlia Blay, Alexandra Baiges et al. · 2024 · Genome Medicine
  52. Anti-integrin αvβ6 autoantibody in primary sclerosing cholangitis: a Japanese nationwide study
    Muneji Yasuda, Masahiro Shiokawa, Takeshi Kuwada, Yoshihiro Nishikawa, Risa Nakanishi, Ikuhisa Takimoto, Koki Chikugo, Masataka Yokode, Yuya Muramoto, Shimpei Matsumoto et al. · 2024 · Journal of Gastroenterology
  53. Cholestatic liver disease: Practice guidelines from the Saudi Association for the Study of Liver diseases and Transplantation
    Mohammad Mawardi, Abduljaleel M. Alalwan, Hind I. Fallatah, Faisal Abdulrahman Abaalkhail, Mohammed Y. Hasosah, Mohammad Ali Shagrani, MohammedY Alghamdi, AbdullahS Alghamdi · 2021 · Saudi Journal of Gastroenterology
  54. The genetic architecture of human amygdala volumes and their overlap with common brain disorders
    Ya-Nan Ou, Bang-Sheng Wu, Yi-Jun Ge, Yi Zhang, Yu-Chao Jiang, Kevin Kuo, Liu Yang, L. Tan, Jian-Feng Feng, W. Cheng et al. · 2023 · Translational Psychiatry
  55. PSC and colitis: A complex relationship
    Ludwig Jesse Horst, Jan Kempski, Martine Walmsley, Samuel Huber, Christoph Schramm · 2025 · Hepatology
  56. Unmet needs in autoimmune liver diseases
    Mirjam Kolev, Andreas Emanuel Kremer, Christiane Sokollik, Merrill Eric Gershwin, Benedetta Terziroli Beretta‐Piccoli, Raul J Andrade, Carina Bobzin, Ynto S. de Boer, Eleonora de Martin, Annamaria Deganello et al. · 2025 · Current Opinion in Immunology
  57. Primary sclerosing cholangitis—A long night's journey into day
    Roger William Chapman · 2022 · Clinical Liver Disease
  58. Impact of Concurrent Non-IBD Immunological Diseases on the Outcome of Primary Sclerosing Cholangitis
    Ramprasad Jegadeesan, Udayakumar Navaneethan, Shishira Bharadwaj, Jeffrey Hammel, Madhusudhan R. Sanaka, Bo Shen · 2016 · Inflammatory Bowel Diseases
  59. Primary sclerosing cholangitis – the Norwegian experience
    Erik Schrumpf, Kirsten Muri Boberg, Tom H. Karlsen · 2015 · Scandinavian Journal of Gastroenterology
  60. How can genetics help understand the relationship between cognitive dysfunction and schizophrenia?
    Olav Bjerkehagen Smeland, Ole A. Andreassen · 2018 · Scandinavian Journal of Psychology
  61. Causal effect of autoimmune liver diseases on cancer: Meta‐analyses of cohort studies and Mendelian randomization study
    Dongqing Gu, Min Zhang, Yutong Wang, Ye Bai, Xin Wang, Guohong Deng · 2022 · Liver International
  62. ANXA1 is identified as a key gene associated with high risk and T cell infiltration in primary sclerosing cholangitis
    Jian Zhang, Huiwen Wang, Jinqing Liu, Lei Fu, Shifang Peng · 2023 · Human Genomics
  63. The gut-liver axis in cholangiopathies: focus on bile acid based pharmacological treatment
    Marica Cariello, Raffaella M. Gadaleta, Antonio Moschetta · 2022 · Current Opinion in Gastroenterology
  64. The efficacy of adalimumab in psoriatic arthritis concomitant to overlapping primary biliary cholangitis and primary sclerosing cholangitis: a case report
    Teresa Del Ross, Amelia Ruffatti, Annarosa Floreani, Ariela Hoxha, Leonardo Punzi · 2016 · BMC Musculoskeletal Disorders
  65. Genetic Risks Link Autoimmune Hepatitis to Other Autoimmune Liver Disease
    Gideon Morris Hirschfield, Tom H. Karlsen · 2014 · Gastroenterology
  66. GPR35 prevents osmotic stress induced cell damage
    Joshua E. Elias, Mekdes Debela, Gavin W. Sewell, Richard J Stopforth, Hannah Partl, Sophie Heissbauer, Lorraine M. Holland, Tom H. Karlsen, Arthur Kaser, Nicole C. Kaneider · 2025 · Communications Biology
  67. AGPAT1 as a Novel Colonic Biomarker for Discriminating Between Ulcerative Colitis With and Without Primary Sclerosing Cholangitis
    Johan Vessby, Jacek R. Wiśniewski, Cecilia Lindskog, Niclas Eriksson, Katja Gabrysch, Katharina Zettl, Alkwin Wanders, Marie Carlson, Fredrik Rorsman, Mikael Åberg · 2022 · Clinical and Translational Gastroenterology
  68. Microbiome, Autoimmune Diseases and HIV Infection: Friends or Foes?
    Chiara Pellicano, Giorgia Leodori, Giuseppe Pietro Innocenti, Antonietta Gigante, Edoardo Rosato · 2019 · Nutrients
  69. Genetic Discoveries Highlight Environmental Factors as Key Drivers of Liver Disease
    Brian K. Chung, Tom H. Karlsen · 2017 · Digestive Diseases
  70. Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications
    Jinyu Zhao, Ping Yue, Ningning Mi, Matu Li, Wenkang Fu, Xianzhuo Zhang, Long Gao, Mingzhen Bai, Liang Tian, Ningzu Jiang et al. · 2024 · Medical Review
  71. The TCF4 Gene Regulates Apoptosis of Corneal Endothelial Cells in Fuchs Endothelial Corneal Dystrophy
    Tatsuya Nakagawa, Tetsuro Honda, Taichi Yuasa, Go Nishiuchi, Masakazu Sato, Ayumi Tokunaga, Makiko Nakahara, Theofilos Tourtas, Ursula M. Schlötzer-Schrehardt, Friedrich Eduard Kruse et al. · 2025 · Investigative Ophthalmology & Visual Science
  72. Potential Association of Doxycycline With the Onset of Primary Sclerosing Cholangitis: A Case Series
    James Gage Buness, Ahmad Hassan Ali, James H. Tabibian, Cynthia W. Buness, Kenneth L. Cox, Keith D. Lindor · 2019 · American Journal of Therapeutics
  73. Chronic recurrent multifocal osteomyelitis and primary sclerosing cholangitis with type 1 autoimmune hepatitis in a child with ulcerative colitis: a case report
    Hon Yan Ng, Orlee R. Guttman, Lori Tucker · 2021 · BMC Rheumatology
  74. Epigenetic Signatures Discriminate Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis From Patients With Ulcerative Colitis
    Manon de Krijger, Ishtu Hageman, Andrew Y. F. Li Yim, Jan Verhoeff, Juan Jesús García-Vallejo, Patricia H. P. van Hamersveld, Evgeni Levin, Theodorus B. M. Hakvoort, Manon E. Wildenberg, Peter Henneman et al. · 2022 · Frontiers in Immunology
  75. Association between serum IgG level and clinical course in primary sclerosing cholangitis
    Theresa Hippchen, Peter Sauer, Benjamin Göppert, Peter Schirmacher, Daniel Nils Gotthardt, Karl-Heinz Weiss, Wolfgang Stremmel, Christian Rupp · 2019 · BMC Gastroenterology
  76. The genetic architecture of human brainstem structures and their involvement in common brain disorders
    Torbjørn Elvsåshagen, Shahram Bahrami, Dennis van der Meer, Ingrid Agartz, Dag Alnæs, Deanna M. Barch, Ramona Baur‐Streubel, Alessandro Bertolino, Mona Kristiansen Beyer, Giuseppe Blasi et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  77. Environmental chemicals and endogenous metabolites in bile of USA and Norway patients with primary sclerosing cholangitis
    Caroline W. Grant, Brian D. Juran, Ahmad Hassan Ali, Erik M. Schlicht, Jackie K. Bianchi, Xin Yang Hu, Yongliang Liang, Zachery Ryan Jarrell, Ken Liu, Young‐Mi Go et al. · 2023 · Exposome
  78. Fine-mapping and molecular characterisation of primary sclerosing cholangitis genetic risk loci
    Elizabeth C. Goode, Laura Fachal, Nikolaos Panousis, Loukas Moutsianas, Rebecca E. McIntyre, Benjamin Y H Bai, Norihito Kawasaki, Alexandra Wittmann, Tim Raine, Simon Rushbrook et al. · 2024 · Nature Communications
  79. Circulating non-coding RNAs as potential diagnostic biomarkers in liver diseases.
    Fedra Mokhtari, Seyed Reza Mohebbi, Afsaneh Sharifian, Marzieh Ramandi, Mohammad Reza Razzaghi · 2021 · PubMed Central
  80. Isolated Crohn's Colitis: Is Localization Crucial? Characteristics of Pediatric Patients From the CEDATA–GPGE Registry
    Lotta Elonen, Lena Wölfle, Jan de Laffolie, Carsten Posovszky, the CEDATA–GPGE-Study-Group · 2022 · Frontiers in Pediatrics
  81. Human leucocyte antigens B*08, DRB1*03 and DRB1*13 are significantly associated with autoimmune liver and biliary diseases in Finnish children
    Elisa Ylinen, L Salmela, Juha P. Peräsaari, Taina Jaatinen, Andrea Tenca, Olli P. Vapalahti, Martti A. Färkkilä, Hannu Jalanko, K‐L Kolho · 2016 · Acta Paediatrica
  82. The Role of Genetic and Immune Factors for the Pathogenesis of Primary Sclerosing Cholangitis in Childhood
    Priscila Menezes Ferri Liu, Ana Cristina Simões e Silva, Soraya Luiza Campos Silva, Diego Junior Queiroga de Aquino, Eleonora Druve Tavares Fagundes, Débora Marques de Miranda, Alexandre Rodrígues Ferreira · 2016 · Gastroenterology Research and Practice
  83. Genetic variation at the CD28 locus and its impact on expansion of pro-inflammatory CD28 negative T cells in healthy individuals
    Evaggelia Liaskou, Louisa E. Jeffery, Dimitrios Chanouzas, Blagoje Soskic, Michael F. Seldin, Lorraine Harper, David Michael Sansom, Gideon Morris Hirschfield · 2017 · Scientific Reports
  84. Genetics of Autoimmune Liver Diseases
    Alessio Gerussi, Marco Carbone, Rosanna Asselta, Pietro Invernizzi · 2020 · Springer eBooks
  85. Genetic Predisposition, Humans
    Margaret A. Jordan, Judith Field, Helmut Butzkueven, Alan G. Baxter · 2013 · Elsevier eBooks
  86. An update on novel pharmacological agents for primary sclerosing cholangitis
    Camilla Gallo, Bright Oworae Howardson, Laura Cristoferi, Marco Carbone, M. Eric Gershwin, Pietro Invernizzi · 2022 · Expert Opinion on Therapeutic Targets
  87. Genetics of Autoimmune Liver Disease: A Brief Summary for Clinicians
    Gwilym James Webb, Gideon Morris Hirschfield · 2014 · Digestive Diseases
  88. Genetic Distinctions in Patients With Primary Sclerosing Cholangitis: Immunoglobulin G4 Elevations and HLA Risk
    Evaggelia Liaskou, Gideon Morris Hirschfield · 2015 · Gastroenterology
  89. Role of genetics in diagnosis and therapy of acquired liver disease
    Vincent Zimmer, Frank Lammert · 2013 · Molecular Aspects of Medicine
  90. Novel Genetic Risk Variants and Clinical Predictors Associated With Primary Sclerosing Cholangitis in Patients With Ulcerative Colitis
    Ming‐Hsi Wang, Jessica J. Friton, Nancy A. Rebert, Kelly M. Monroe, Billy Darren Nix, Claudio Fiocchi, Laura E. Raffals, Jonathan A. Leighton, Shabana F. Pasha, Michael F. Picco et al. · 2023 · Clinical and Translational Gastroenterology
  91. Beyond genome-wide association studies: Investigating the role of noncoding regulatory elements in primary sclerosing cholangitis
    Henry Pratt, Tong Wu, Shaimae I. Elhajjajy, Jeffrey Zhou, Kate Fitzgerald, Tom Fazzio, Zhiping Weng, Daniel Stephan Pratt · 2023 · Hepatology Communications
  92. Polygenic risk score predicts risk of primary sclerosing cholangitis in inflammatory bowel disease
    Ming‐Hsi Wang, Jessica J. Friton, Laura E. Raffals, Jonathan A. Leighton, Shabana F. Pasha, Michael F. Picco, Kelly M. Monroe, Billy Darren Nix, Rodney D. Newberry, William A. Faubion · 2023 · BMJ Open Gastroenterology
  93. Inflammatory Bowel Disease (IBD)—A Textbook Case for Multi-Centric Banking of Human Biological Materials
    Isabelle Cleynen, Loes Linsen, Sare Verstockt, Bram Verstockt, Vera Ballet, Eline Vandeput, Gert Van Assche, Marc Ferrante, Kristel Van Landuyt, Séverine Vermeire et al. · 2019 · Frontiers in Medicine
  94. No replication of previously reported association with genetic variants in the T cell receptor alpha (TRA) locus for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
    Marthe Ueland, Riad Hajdarevic, Olav Mella, Elin Bolle Strand, Daisy D. Sosa, Ola Didrik Saugstad, Øystein Fluge, Benedicte Alexandra Lie, Marte Kathrine Viken · 2022 · Translational Psychiatry
  95. Cross-disorder analysis of schizophrenia and 19 immune diseases reveals genetic correlation
    Jennie G Pouget, Buhm Han, Yang Wu, Emmanuel Jean-Marie Mignot, Hanna Maria Ollila, Jonathan Barker, Sarah Spain, Nick Dand, Richard C. Trembath, Javier Martin et al. · 2016 · bioRxiv (Cold Spring Harbor Laboratory)
  96. Genetic architecture of primary biliary cholangitis: strong evidence for HLA and non-HLA risk loci
    Min Zhang, Liang Lyu, Liang Ge, Yizhou Wang, Dongqing Gu · 2025 · Frontiers in Immunology
  97. Autoimmune liver diseases, hepatocellular carcinoma, and recurrence of autoimmunity post-liver transplantation
    Sarah Wang, Victor Dong, Aldo J. Montaño‐Loza, Andrew L. Mason · 2021 · Hepatoma Research
  98. Colangiocarcinoma en pacientes con colangitis esclerosante primaria
    Camila Andrea Guerrero-Bermúdez, Mariana Vélez-Marín, Juan Carlos Restrepo · 2018 · Revista Colombiana de Gastroenterología
  99. Variants of autoimmune liver diseases: how to diagnose? how to treat?
    Maciej K. Janik, Ewa Wunsch, Piotr Milkiewicz · 2023 · Polskie Archiwum Medycyny Wewnętrznej
  100. Primary sclerosing cholangitis and inflammatory bowel disease: a complicated yet unique relationship
    Matteo Peviani, Nora Cazzagon, Martina Gambato, Luisa Bertin, Fabiana Zingone, Edoardo V. SAVARINO, B Barberio · 2024 · Minerva Gastroenterology